Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 4, 2009, Pages 195-200

  Chen, Haiying ^a   Qin, Jin ^a   Wei, Ping ^a   Zhang, Jingge ^a   Li, Qiaoxia ^a   Fu, Lihong ^a   Li, Shujin ^a   Ma, Chunling ^a   Cong, Bin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Foxp3; Leukotriene; Prostaglandin; Regulatory T cells; ROR t; Th17 cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; L SELECTIN; LEUKOTRIENE B4; MESSENGER RNA; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR ROR GAMMA T; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL;

ANIMALS; CELL DIFFERENTIATION; DINOPROSTONE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOLOGIC FACTORS; INTERLEUKIN-17; INTERLEUKIN-6; LEUKOTRIENE B4; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

MURINAE;

EID: 67349189454     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.01.006     Document Type: Article

References (33)

1. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285-1294
2. Baecher-Allan C., and Hafler D.A. Suppressor T cells in human diseases. J. Exp. Med. 200 (2004) 273-276
3. Ehrenstein M.R., Evans J.G., Singh A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF alpha therapy. J. Exp. Med. 200 (2004) 277-285
4. Haas J., Hug A., Viehover A., et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35 (2005) 3343-3352
5. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
6. Mangan P.R., Harrington L.E., O'Quinn D.B., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
7. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
8. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nature Immunol. 4 (2003) 330-336
9. Wan Y.Y., and Flavell R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102 (2005) 5126-5131
10. Ivanov I.I., McKenzie B.S., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006) 1121-1133
11. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends. Immunol. 23 (2002) 144-150
12. Sheibanie A.F., Yen J.H., Khayrullina T., et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis. J. Immunol. 178 (2007) 8138-8147
13. Sheibanie A.F., Khayrullina T., Safadi F.F., and Ganea D. Prostaglandin E2 exacerbates collagen- induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis. Rheum. 56 (2007) 2608-2619
14. Khayrullina T., Yen J.H., Jing H., and Ganea D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J. Immunol. 181 (2008) 721-735
15. Mahic M., Yaqub S., Johansson C.C., Tasken K., and Aandahl E.M. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 177 (2006) 246-254
16. Baratelli F., Lin Y., Zhu L., et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175 (2005) 1483-1490
17. Sharma S., Yang S.C., Zhu L., et al. Tumor cyclooxygenase -2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res. 65 (2005) 5211-5220
18. Jozefowski S., Biedron R., Bobek M., and Marcinkiewicz J. Leukotrienes modulate cytokine release from dendritic cells. Immunology 116 (2005) 418-428
19. Terawaki K., Yokomizo T., Nagase T., et al. Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J. Immunol. 175 (2005) 4217-4225
20. Kim D.C., Hsu F.I., Barrett N.A., et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J. Immunol. 176 (2006) 4440-4448
21. Miyahara N., Ohnishi H., Matsuda H., et al. Leukotriene B4 receptor 1 expression on dendritic cells is required for the development of Th2 responses and allergen-induced airway hyperresponsiveness. J. Immunol. 181 (2008) 1170-1178
22. Rainer T.H. L-selectin in health and disease. Resuscitation 52 (2002) 127-141
23. Honda T., Segi-Nishida E., Miyachi Y., and Narumiya S. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J. Exp. Med. 203 (2006) 325-335
24. McCoy J.M., Wicks J.R., and Audoly L.P. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest. 110 (2002) 651-658
25. Shao W.H., Del Prete A., Bock C.B., and Haribabu B. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. J. Immunol. 176 (2006) 6254-6261
26. Afazali B., Lombardi G., Lechler R.I., and Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148 (2007) 32-46
27. Nelson B.H. IL-2, regulatory T cells, and tolerance. J. Immunol. 172 (2004) 3983-3988
28. de la Rosa M., Rutz S., Dorninger H., and Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34 (2004) 2480-2488
29. Anastassiou E.D., Paliogianni F., Balow J.P., Yamada H., and Boumpas D.T. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J. Immunol. 148 (1992) 2845-2852
30. fyn tyrosine kinase in T lymphocytes during sepsis. J. Immunol. 160 (1998) 929-935
31. Cosme R., Lublin D., Takafuji V., Lynch K., and Roche J.K. Prostanoids in human colonic mucosa: effects of inflammation on PGE2 receptor expression. Hum. Immunol. 61 (2000) 684-696
32. Benczik M., and Gaffen S.L. The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol. Invest. 33 (2004) 109-142
33. Harizi H., and Gualde N. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens. 65 (2005) 507-514